Valuation: Jinyu Bio-technology Co., Ltd.

Capitalization 1.55TCr 228.65Cr 195.27Cr 178.91Cr 169.14Cr 313.21Cr 22TCr 314.83Cr 2.13TCr 829.37Cr 10TCr 857.95Cr 839.95Cr 36TCr P/E ratio 2026 *
59.2x
P/E ratio 2027 * 40x
Enterprise value 1.55TCr 228.65Cr 195.27Cr 178.91Cr 169.14Cr 313.21Cr 22TCr 314.83Cr 2.13TCr 829.37Cr 10TCr 857.95Cr 839.95Cr 36TCr EV / Sales 2026 *
9.37x
EV / Sales 2027 * 8.78x
Free-Float
79.33%
Yield 2026 *
0.56%
Yield 2027 * 0.81%
1 day-7.00%
1 week-2.60%
Current month-2.60%
1 month-5.01%
3 months-9.95%
6 months+32.06%
Current year-5.71%
1 week 14.06
Extreme 14.06
15.61
1 month 13.35
Extreme 13.35
15.61
Current year 13.14
Extreme 13.14
19
1 year 6.95
Extreme 6.95
19
3 years 5.62
Extreme 5.62
19
5 years 5.62
Extreme 5.62
21.87
10 years 5.62
Extreme 5.62
31.15
Manager TitleAgeSince
Director of Finance/CFO 40 31/05/2022
Human Resources Officer 44 01/06/2020
President 43 21/05/2019
Director TitleAgeSince
Chairman 72 01/05/1993
Director/Board Member 43 31/05/2022
Director/Board Member 58 26/04/2019
Change 5d. change 1-year change 3-years change Capi.($)
-7.00%-2.60%+101.27%+25.64% 245.83Cr
-2.68%-32.70%-53.34%-59.29% 3.23TCr
+2.08%-16.42%+68.05%+145.84% 1.07TCr
-1.25%-4.89%+28.06%+55.09% 580.41Cr
-1.30%-6.32%+11.26%+11.44% 339.38Cr
+1.01%-3.21%-19.86%-8.02% 169.58Cr
-3.61%-39.66%+43.50%+144.80% 148.39Cr
+0.90%-0.50%-19.36%-8.85% 118.66Cr
-0.95%-3.32%+6.91%-47.40% 110.35Cr
-0.07%+2.50%-11.56%-40.40% 100.95Cr
Average -1.32%-8.71%+15.49%+21.89% 610.94Cr
Weighted average by Cap. -1.61%-19.30%-8.81%+2.75%

Financials

2026 *2027 *
Net sales 165.7Cr 24Cr 21Cr 19Cr 18Cr 33Cr 2.34TCr 34Cr 227.34Cr 89Cr 1.11TCr 92Cr 90Cr 3.85TCr 176.9Cr 26Cr 22Cr 20Cr 19Cr 36Cr 2.49TCr 36Cr 242.7Cr 94Cr 1.18TCr 98Cr 96Cr 4.11TCr
Net income 27Cr 3.95Cr 3.37Cr 3.09Cr 2.92Cr 5.41Cr 377.69Cr 5.43Cr 37Cr 14Cr 179.23Cr 15Cr 14Cr 622.98Cr 40Cr 5.82Cr 4.97Cr 4.56Cr 4.31Cr 7.98Cr 557.38Cr 8.02Cr 54Cr 21Cr 264.5Cr 22Cr 21Cr 919.36Cr
Net Debt - -
Logo Jinyu Bio-technology Co., Ltd.
Jinyu Bio-Technology Co Ltd is a China-based company primarily engaged in the research and development, production, and sale of veterinary biological products. The Company’s product portfolio covers four major series of animal vaccines for swine, avian, ruminants, and companion animal. The Company’s products are mainly used to prevent animal diseases such as foot-and-mouth disease, porcine circovirus disease, mycoplasmas pneumonia of swine, porcine reproductive and respiratory syndrome, pseudorabies, highly pathogenic avian influenza, brucellosis, bovine viral diarrhea or mucosal disease, lumpy skin disease, infectious bovine rhinotracheitis, feline triple vaccine, and rabies. The Company conducts its business in the domestic and overseas markets.
Employees
1,740
Date Price Change Volume
13/26/13 14.21 ¥ -7.00% 5,54,20,760
12/26/12 15.28 ¥ -0.20% 3,34,35,800
11/26/11 15.31 ¥ +1.46% 3,54,57,890
08/26/08 15.09 ¥ +1.48% 3,10,00,310
07/26/07 14.87 ¥ +1.43% 2,88,53,570
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
14.21CNY
Average target price
17.35CNY
Spread / Average Target
+22.10%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600201 Stock